We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HIFS:NASDAQHingham Institution for Savings Analysis

Data as of 2026-06-18 - not real-time

$282.24

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Hingham Institution for Savings (HIFS) is trading at $282.24, notably below its 20‑day ($286.15) and 50‑day ($286.18) simple moving averages, signaling a short‑term bearish bias despite a bullish MACD crossover (MACD line $1.72 vs signal $1.68). Valuation metrics are attractive: a trailing P/E of 12.37 is well under the industry average of 17.05 and the price‑to‑book of 1.28 suggests the stock is undervalued relative to peers. However, the company faces material headwinds – revenue has contracted 30.5%, debt sits at $1.41 B with minimal cash reserves, and recent news flags rising non‑accrual loans, weak net interest margins, and elevated commercial‑real‑estate exposure, all of which amplify risk.
The technical picture is mixed: volatility is high at 31% over 30 days and beta exceeds 1, indicating sensitivity to market swings, while volume is trending upward, hinting at accumulating interest near the support level of $266.58. Strong profitability (profit margin 51.6% and ROE ~11%) provides a cushion, but the lack of dividend and uncertain earnings outlook (forward EPS unavailable) temper enthusiasm. Investors should weigh the attractive valuation against the pronounced asset‑quality concerns and leverage profile before positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price below short‑term SMAs indicating bearish momentum
  • Asset‑quality concerns and high debt increase downside risk
  • Increasing volume suggests potential bottoming near support

Medium Term

1–3 years
Positive
Model confidence: 6/10

Key Factors

  • Attractive valuation relative to industry peers
  • Strong profit margins and ROE provide earnings resilience
  • Technical bullish MACD and rising volume may support a rebound

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Persistent CRE and non‑accrual loan exposure limit upside
  • High leverage and limited cash buffer heighten structural risk
  • Value orientation may sustain price stability if fundamentals improve

Key Metrics & Analysis

Financial Health

Revenue Growth-30.50%
Profit Margin51.56%
P/E Ratio12.4
ROE10.93%
ROA1.11%
P/B Ratio1.3
Op. Cash Flow$37.4M
Industry P/E17.1

Technical Analysis

TrendBearish
RSI47.2
Support$266.58
Resistance$300.99
MA 20$286.15
MA 50$286.18
MA 200$286.88
MACDBullish
VolumeIncreasing
Fear & Greed Index88.5

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.16
Volatility31.26%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.